Fund profile / France

Sanofi Ventures

Geography
France
Stage
Seed
Fund size
$625M
Focus
Biotech and Digital Health
Signals
Published
Share
N°01 / About

About Sanofi Ventures

Biotech, Digital Health, Immunology, Neurology, Rare Diseases, Vaccines - evergreen fund

N°02 / Thesis

Investment Focus

Location / RegionFrance
Funding StageSeed
Industry Focus
Biotech
Digital Health

Investor Signals Profile

active

Sweet Spot

Early-stage biotech with pharma M&A potential, now oncology angle

immunology
rare diseases
neurology
vaccines
digital health
oncology
conditional antibodies
precision immunotherapy

Bullish Signals

$625M new commitment, $1.4B AUMexternal
11 deals closed in 2025 alreadyexternal
3 exits, $3.25B combined in 2024external
Actively leading rounds vs. traditional VCsexternal
Sanofi pushing derm access — digital health signallinkedin
Meningococcal vaccine expansion — infant indication EU approvedlinkedin
Conditional antibodies, tumor-targeted immunotherapy focuslinkedin
Oncology precision immunotherapy expanding investment mandatelinkedin

Contrarian Signals

Source is Sanofi, not a VC fundexternal
Strategic CVC — agenda tied to Sanofi pipelineexternal
Acquisition bias may limit founder independenceexternal
LinkedIn content brand-focused, low deal signallinkedin
Partner Spotlight format — PR, not investment signallinkedin
Sports sponsorship content — ESG, not healthcare thesislinkedin

Founder Do's

Target immunology, neuro, rare disease, vaccines
Open to seed through crossover stage
Show clear M&A attractiveness to big pharma
Prepare strong clinical/preclinical data package
Ophthalmology also on radar
Oncology precision immunotherapy gaining traction
Tumor microenvironment tech aligned with Sanofi strategy

Founder Don'ts

Don't expect passive investor — they co-lead
Don't ignore strategic fit with Sanofi pipeline
Don't pitch without clear exit narrative

26 signals on Sanofi Ventures

8 bullish · 6 contrarian · 7 pitch do's · 3 don'ts · 2 GP profiles, each with its source. From €9/month, cancel anytime.

Facts

Fund Overview

Fund Size$625M
Saves0
People

Key People

Jason P. Hafler

Jason HaflerManaging Director
Zandra KlippelTherapeutic Area Head, Oncology
N°04 / See also

Related Funds

Capagro

Fund size€115M
Location
France
Stage
Series A
Focus
Saas
Manager
Tom Espiard Cignaco, Maxime Walter
Series A
Saas

makesense Seed II

Fund size€25M
Location
France
Stage
Pre Seed
Focus
Circular Economy, Climate Sustainability
Manager
makesense
Pre Seed
Circular Economy
Climate Sustainability

Don't Quit Ventures

Fund size$10M
Location
France
Stage
Pre Seed
Focus
Manager
Noa Khamallah
Pre Seed